vs
Forge Global Holdings, Inc.（FRGE）与RECURSION PHARMACEUTICALS, INC.（RXRX）财务数据对比。点击上方公司名可切换其他公司
RECURSION PHARMACEUTICALS, INC.的季度营收约是Forge Global Holdings, Inc.的1.7倍（$35.5M vs $21.3M），Forge Global Holdings, Inc.净利率更高（-85.7% vs -304.2%，领先218.5%），RECURSION PHARMACEUTICALS, INC.同比增速更快（681.7% vs 10.6%），Forge Global Holdings, Inc.自由现金流更多（$-11.4M vs $-47.3M），过去两年RECURSION PHARMACEUTICALS, INC.的营收复合增速更高（60.5% vs 5.6%）
该公司原本信息存在混淆，此处对应描述中的巴拉特锻造是一家印度跨国企业，业务涵盖锻造、汽车、能源、建筑采矿、铁路、船舶、航空航天和国防等多个领域，是印度工业领域颇具影响力的核心制造企业。
Recursion Pharmaceuticals是一家临床阶段生物技术企业，依托人工智能技术和高通量生物实验体系，开发针对罕见病、肿瘤、炎症性疾病等领域未满足医疗需求的创新疗法，核心市场覆盖北美，与全球多家生物制药企业合作推进在研管线落地。
FRGE vs RXRX — 直观对比
损益表 — Q3 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $21.3M | $35.5M |
| 净利润 | $-18.2M | $-108.1M |
| 毛利率 | 98.6% | 59.8% |
| 营业利润率 | -96.7% | -304.8% |
| 净利率 | -85.7% | -304.2% |
| 营收同比 | 10.6% | 681.7% |
| 净利润同比 | 0.6% | 39.6% |
| 每股收益（稀释后） | $-1.37 | $-0.17 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
| Q4 25 | — | $35.5M | ||
| Q3 25 | $21.3M | $5.2M | ||
| Q2 25 | $27.7M | $19.2M | ||
| Q1 25 | $25.3M | $14.7M | ||
| Q4 24 | $18.6M | $4.5M | ||
| Q3 24 | $19.2M | $26.1M | ||
| Q2 24 | $22.3M | $14.4M | ||
| Q1 24 | $19.2M | $13.8M |
| Q4 25 | — | $-108.1M | ||
| Q3 25 | $-18.2M | $-162.3M | ||
| Q2 25 | $-12.6M | $-171.9M | ||
| Q1 25 | $-16.2M | $-202.5M | ||
| Q4 24 | $-15.6M | $-178.9M | ||
| Q3 24 | $-18.3M | $-95.8M | ||
| Q2 24 | $-13.7M | $-97.5M | ||
| Q1 24 | $-18.6M | $-91.4M |
| Q4 25 | — | 59.8% | ||
| Q3 25 | 98.6% | -183.8% | ||
| Q2 25 | 99.4% | -4.9% | ||
| Q1 25 | 99.2% | -48.0% | ||
| Q4 24 | 98.3% | -181.4% | ||
| Q3 24 | 99.6% | 53.7% | ||
| Q2 24 | 98.9% | 36.2% | ||
| Q1 24 | 99.8% | 19.1% |
| Q4 25 | — | -304.8% | ||
| Q3 25 | -96.7% | -3327.6% | ||
| Q2 25 | -46.3% | -916.8% | ||
| Q1 25 | -65.1% | -1297.9% | ||
| Q4 24 | -100.6% | -4042.4% | ||
| Q3 24 | -108.8% | -377.1% | ||
| Q2 24 | -79.2% | -697.4% | ||
| Q1 24 | -130.0% | -698.4% |
| Q4 25 | — | -304.2% | ||
| Q3 25 | -85.7% | -3135.3% | ||
| Q2 25 | -45.4% | -894.2% | ||
| Q1 25 | -63.9% | -1373.3% | ||
| Q4 24 | -84.2% | -3935.5% | ||
| Q3 24 | -95.5% | -367.5% | ||
| Q2 24 | -61.6% | -676.6% | ||
| Q1 24 | -96.8% | -662.4% |
| Q4 25 | — | $-0.17 | ||
| Q3 25 | $-1.37 | $-0.36 | ||
| Q2 25 | $-1.01 | $-0.41 | ||
| Q1 25 | $-1.29 | $-0.50 | ||
| Q4 24 | $3.81 | $-0.56 | ||
| Q3 24 | $-1.49 | $-0.34 | ||
| Q2 24 | $-1.13 | $-0.40 | ||
| Q1 24 | $-1.55 | $-0.39 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $60.7M | $743.3M |
| 总债务越低越好 | — | $9.6M |
| 股东权益账面价值 | $202.6M | $1.1B |
| 总资产 | $252.0M | $1.5B |
| 负债/权益比越低杠杆越低 | — | 0.01× |
8季度趋势，按日历期对齐
| Q4 25 | — | $743.3M | ||
| Q3 25 | $60.7M | $659.8M | ||
| Q2 25 | $80.7M | $525.1M | ||
| Q1 25 | $92.0M | $500.5M | ||
| Q4 24 | $105.1M | $594.4M | ||
| Q3 24 | $114.5M | $427.6M | ||
| Q2 24 | $120.5M | $474.3M | ||
| Q1 24 | $129.6M | $296.3M |
| Q4 25 | — | $9.6M | ||
| Q3 25 | — | $11.9M | ||
| Q2 25 | — | $14.2M | ||
| Q1 25 | — | $16.4M | ||
| Q4 24 | — | $19.0M | ||
| Q3 24 | — | $20.5M | ||
| Q2 24 | — | $22.9M | ||
| Q1 24 | — | — |
| Q4 25 | — | $1.1B | ||
| Q3 25 | $202.6M | $1.0B | ||
| Q2 25 | $200.5M | $919.1M | ||
| Q1 25 | $213.5M | $933.9M | ||
| Q4 24 | $223.6M | $1.0B | ||
| Q3 24 | $234.5M | $524.6M | ||
| Q2 24 | $245.4M | $584.4M | ||
| Q1 24 | $252.2M | $401.2M |
| Q4 25 | — | $1.5B | ||
| Q3 25 | $252.0M | $1.4B | ||
| Q2 25 | $242.8M | $1.3B | ||
| Q1 25 | $249.5M | $1.3B | ||
| Q4 24 | $263.5M | $1.4B | ||
| Q3 24 | $276.6M | $726.5M | ||
| Q2 24 | $285.7M | $775.9M | ||
| Q1 24 | $298.7M | $557.8M |
| Q4 25 | — | 0.01× | ||
| Q3 25 | — | 0.01× | ||
| Q2 25 | — | 0.02× | ||
| Q1 25 | — | 0.02× | ||
| Q4 24 | — | 0.02× | ||
| Q3 24 | — | 0.04× | ||
| Q2 24 | — | 0.04× | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-11.4M | $-46.1M |
| 自由现金流经营现金流 - 资本支出 | $-11.4M | $-47.3M |
| 自由现金流率自由现金流/营收 | -53.6% | -133.1% |
| 资本支出强度资本支出/营收 | 0.2% | 3.5% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $-73.5M | $-378.3M |
8季度趋势，按日历期对齐
| Q4 25 | — | $-46.1M | ||
| Q3 25 | $-11.4M | $-117.4M | ||
| Q2 25 | $-7.8M | $-76.4M | ||
| Q1 25 | $-12.8M | $-132.0M | ||
| Q4 24 | $-40.5M | $-115.4M | ||
| Q3 24 | $-5.8M | $-59.2M | ||
| Q2 24 | $-14.4M | $-82.2M | ||
| Q1 24 | $-12.4M | $-102.3M |
| Q4 25 | — | $-47.3M | ||
| Q3 25 | $-11.4M | $-117.6M | ||
| Q2 25 | $-7.9M | $-79.6M | ||
| Q1 25 | $-12.9M | $-133.8M | ||
| Q4 24 | $-41.3M | $-116.7M | ||
| Q3 24 | $-6.0M | $-63.8M | ||
| Q2 24 | $-14.7M | $-83.4M | ||
| Q1 24 | $-12.8M | $-109.0M |
| Q4 25 | — | -133.1% | ||
| Q3 25 | -53.6% | -2272.5% | ||
| Q2 25 | -28.4% | -413.9% | ||
| Q1 25 | -50.9% | -907.4% | ||
| Q4 24 | -222.3% | -2567.7% | ||
| Q3 24 | -31.0% | -244.6% | ||
| Q2 24 | -66.0% | -578.5% | ||
| Q1 24 | -66.4% | -789.9% |
| Q4 25 | — | 3.5% | ||
| Q3 25 | 0.2% | 4.7% | ||
| Q2 25 | 0.4% | 16.4% | ||
| Q1 25 | 0.2% | 12.4% | ||
| Q4 24 | 4.3% | 28.6% | ||
| Q3 24 | 0.7% | 17.5% | ||
| Q2 24 | 1.2% | 8.2% | ||
| Q1 24 | 2.1% | 48.2% |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
FRGE
| Marketplace | $12.2M | 57% |
| Custodial Administration Fees | $9.1M | 43% |
RXRX
暂无分部数据
